Evidence map›Paper›PMID 34730706›Full record

ArticleEinstein (Sao Paulo, Brazil)

Neurological and neuropsychiatric disorders associated with COVID-19. Part II: neuropsychiatric disorders and final consideration.

Martina Giacalone, Marcos Roberto Tovani-Palone, Luca Marin, Massimiliano Febbi, Tommaso Russano, Andrea Giacalone

Abstract readLetter
In one paragraph

Article in Einstein (Sao Paulo, Brazil). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martina GiacaloneFaculty of Medicine and Pharmacy, Medicine and Surgery, Sapienza University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0002-2210-8501
Marcos Roberto Tovani-PaloneFaculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.ORCID http://orcid.org/0000-0003-1149-2437
Luca MarinDepartment of Rehabilitation, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.ORCID http://orcid.org/0000-0002-4185-7428
Massimiliano FebbiDepartment of Rehabilitation, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.ORCID http://orcid.org/0000-0003-1091-997X
Tommaso RussanoDepartment of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0003-4307-5080
Andrea GiacaloneDepartment of Industrial Engineering, Technologies for Sports Medicine and Rehabilitation, University of Rome Tor Vergata, Rome, Italy.ORCID http://orcid.org/0000-0002-4779-0340

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Mental DisordersNervous System DiseasesHumansSARS-CoV-2

Identifiers

PMID34730706
PMCPMC8528448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.